Laddar...
Application of CRISPR/Cas9 Technology to HBV
More than 240 million people around the world are chronically infected with hepatitis B virus (HBV). Nucleos(t)ide analogs and interferon are the only two families of drugs to treat HBV currently. However, none of these anti-virals directly target the stable nuclear covalently closed circular DNA (c...
Sparad:
| Huvudupphovsmän: | , , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
MDPI AG
2015-11-01
|
| Serie: | International Journal of Molecular Sciences |
| Ämnen: | |
| Länkar: | http://www.mdpi.com/1422-0067/16/11/25950 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|